Artemisinin resistance: current status and scenarios for containment

被引:487
作者
Dondorp, Arjen M. [1 ,2 ]
Yeung, Shunmay [1 ,3 ]
White, Lisa [1 ,2 ]
Nguon, Chea [3 ]
Day, Nicholas P. J. [1 ,2 ]
Socheat, Duong [3 ,4 ]
von Seidlein, Lorenz [1 ,5 ]
机构
[1] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok 10400, Thailand
[2] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England
[3] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[4] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia
[5] Joint Malaria Project, Tanga, Tanzania
基金
英国惠康基金;
关键词
UNCOMPLICATED FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; ARTESUNATE-MEFLOQUINE; COMBINATION THERAPY; DRUG-RESISTANCE; ARTEMETHER-LUMEFANTRINE; CHLOROQUINE RESISTANCE; ANTIMALARIAL EFFICACY; CYTOCHROME-B; IN-VITRO;
D O I
10.1038/nrmicro2331
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Artemisinin combination therapies are the first-line treatments for uncomplicated Plasmodium falciparum malaria in most malaria-endemic countries. Recently, partial artemisinin-resistant P. falciparum malaria has emerged on the Cambodia-Thailand border. Exposure of the parasite population to artemisinin monotherapies in subtherapeutic doses for over 30 years, and the availability of substandard artemisinins, have probably been the main driving force in the selection of the resistant phenotype in the region. A multifaceted containment programme has recently been launched, including early diagnosis and appropriate treatment, decreasing drug pressure, optimising vector control, targeting the mobile population, strengthening management and surveillance systems, and operational research. Mathematical modelling can be a useful tool to evaluate possible strategies for containment.
引用
收藏
页码:272 / 280
页数:9
相关论文
共 69 条
[1]   Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial [J].
Achan, Jane ;
Tibenderana, James K. ;
Kyabayinze, Daniel ;
Mangen, Fred Wabwire ;
Kamya, Moses R. ;
Dorsey, Grant ;
D'Alessandro, Umberto ;
Rosenthal, Philip J. ;
Talisuna, Ambrose O. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :283
[2]  
Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8
[3]   PFMDR1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border [J].
Alker, Alisa P. ;
Lim, Pharath ;
Sem, Rithy ;
Shah, Naman K. ;
Yi, Poravuth ;
Bouth, Denis Mey ;
Tsuyuoka, Reiko ;
Maguire, Jason D. ;
Fandeur, Thierry ;
Ariey, Frederic ;
Wongsrichanalai, Chansuda ;
Meshnick, Steven R. .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 76 (04) :641-647
[4]  
ANDERSON T, J INFECT DI IN PRESS
[5]  
[Anonymous], 2007, Wkly Epidemiol Rec, V82, P360
[6]   Drug therapy: Effectiveness of antimalarial drugs [J].
Baird, JK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1565-1577
[7]   Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa [J].
Barnes, KI ;
Durrheim, DN ;
Little, F ;
Jackson, A ;
Mehta, U ;
Allen, E ;
Dlamini, SS ;
Tsoka, J ;
Bredenkamp, B ;
Mthembu, DJ ;
White, NJ ;
Sharp, BL .
PLOS MEDICINE, 2005, 2 (11) :1123-1134
[8]   Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar [J].
Bhattarai, Achuyt ;
Ali, Abdullah S. ;
Kachur, S. Patrick ;
Martensson, Andreas ;
Abbas, Ali K. ;
Khatib, Rashid ;
Al-Mafazy, Abdul-wahiyd ;
Ramsan, Mahdi ;
Rotllant, Guida ;
Gerstenmaier, Jan F. ;
Molteni, Fabrizio ;
Abdulla, Salim ;
Montgomery, Scott M. ;
Kaneko, Akira ;
Bjorkman, Anders .
PLOS MEDICINE, 2007, 4 (11) :1784-1790
[9]   Benefits of using multiple first-line therapies against malaria [J].
Boni, Maciej F. ;
Smith, David L. ;
Laxminarayan, Ramanan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (37) :14216-14227
[10]   Gluclose-6-phosphate dehydrogenase deficiency [J].
Cappellini, M. D. ;
Fiorelli, G. .
LANCET, 2008, 371 (9606) :64-74